Dr. Yongtao Li 李涌涛
Chief Physician
Department of Breast Surgery, Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Early diagnosis of breast malignancies; standardized surgeries including mastectomy, breast-conserving surgery, sentinel lymph node biopsy, and post-operative reconstruction; minimally invasive removal of benign tumors; precise localization and excision of clustered calcifications.
Dr. Li holds a medical doctorate and serves as Deputy Department Director. With years of specialized experience in breast care, Dr. Li focuses on early tumor diagnosis, reconstructive and breast-conserving surgeries, sentinel lymph node procedures, and radical operations, adhering to standardized comprehensive treatment protocols for breast cancer.
Professional roles
- Youth Member, Breast Cancer Professional Committee, China Anti-Cancer Association
Name order: in Chinese the family name comes first (Li Yongtao). Papers usually list the name as Yongtao Li or Li Y.
Selected publications
13 papers on PubMed matched by name and affiliation; 4 as first or senior author since 2016. Most recent first- or senior-author papers:
- Front Oncol, 2026 (senior author): Beyond chaperoning: HSPA8 modulates alternative splicing of PPP2R2D to drive apoptotic evasion and macrophage-associated immune microenvironment remodeling in triple-negative breast cancer. PubMed 42898301
- Front Oncol, 2025 (first author): Response and prognosis to neoadjuvant chemotherapy in women early breast cancer of HER2-low status. PubMed 40552265
- Aging (Albany NY), 2023 (senior author): HNRNPA2B1 is a potential biomarker of breast cancer related to prognosis and immune infiltration. PubMed 37671941
- Dis Markers, 2022 (senior author): HSPA8 Is a New Biomarker of Triple Negative Breast Cancer Related to Prognosis and Immune Infiltration. PubMed 36452344
- Eur J Med Res, 2015 (first author): PALB2 mutations in breast cancer patients from a multi-ethnic region in northwest China. PubMed 26489409
- Eur J Med Res, 2014 (first author): The prevalence of BRCA1/2 mutations of triple-negative breast cancer patients in Xinjiang multiple ethnic region of China. PubMed 24961674
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion